| Literature DB >> 21439036 |
France Denoeud1, Michaël Roussel, Benjamin Noel, Ivan Wawrzyniak, Corinne Da Silva, Marie Diogon, Eric Viscogliosi, Céline Brochier-Armanet, Arnaud Couloux, Julie Poulain, Béatrice Segurens, Véronique Anthouard, Catherine Texier, Nicolas Blot, Philippe Poirier, Geok Choo Ng, Kevin S W Tan, François Artiguenave, Olivier Jaillon, Jean-Marc Aury, Frédéric Delbac, Patrick Wincker, Christian P Vivarès, Hicham El Alaoui.
Abstract
BACKGROUND: Blastocystis is a highly prevalent anaerobic eukaryotic parasite of humans and animals that is associated with various gastrointestinal and extraintestinal disorders. Epidemiological studies have identified different subtypes but no one subtype has been definitively correlated with disease.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21439036 PMCID: PMC3129679 DOI: 10.1186/gb-2011-12-3-r29
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
General features of Blastocystis sp. subtype 7
| Number | Mean length | Median length | Total length (Mb) | Percentage of genome (18.8 Mb) | |
|---|---|---|---|---|---|
| Genes | 6,020 | 1,299 | 1,397 | 7.82 | 42% |
| Exons | 24,580 | 280 | 150 | 6.88 | 37% |
| Introns | 18,560 | 50.5 | 31 | 0.94 | 5% |
| Intergenic | - | 1,801 | 4,092 | 10.9 | 58% |
| Repeats | 2,730 | 1,747 | 2,862 | 4.8 | 25% |
Figure 1Blocks of duplicated genes in the . For each scaffold (from 0 to 25), the duplicated blocks are displayed with colors corresponding to the scaffolds where the paralogous blocks are located (on scaffolds 0 to 19, 21, 22, 24, 25, 27, 28, 30). Below each scaffold, the repeat density is displayed as a grey scale: 0% (white) to 100% (black) repeats in 10-kb windows.
Figure 2. The proteins are predicted from the combined analysis of MitoProt and MitoPred algorithms. Proteins with a predicted amino-terminal extension are outlined by a solid black line, and protein complexes for which mitochondrial presequences for only some of the subunits have been predicted are outlined by a dashed black line. The pathways in purple represent: (1) the conversion of pyruvate into acetyl-CoA by the pyruvate dehydrogenase complex (PDH), pyruvate:ferredoxin oxidoreductase (PFO) or pyruvate:NADP oxidoreductase (PNO); (2) acetyl-CoA is then converted to acetate by acetate:succinate CoA transferase (ASCT) and may allow production of ATP (3). Pyruvate may follow routes that potentially use complexes I and II to produce succinate (and propionate) and certainly participate in maintaining the redox balance. The pathways in green and burgundy correspond to amino acid metabolism and fatty acid metabolism, respectively. Pathways for the assembly of iron-sulfur proteins are represented in blue, and proteins involved in mitochondrial import machinery in orange. Enzymes that may play a role in protection against oxidative stress are indicated in pink (superoxide dismutase (SOD), alternative oxidase (AOX), glutathione reductase (GR) and gluthathione peroxidase (GPx)); the role of glycerol-3-phosphate dehydrogenase (G3PDH) remains to be determined. Abbreviations: 1, acetyl-CoA carboxylase; 2, 3-oxoacyl-ACP synthase; 3, 3-oxoacyl-ACP reductase; 4, 2-enoyl-ACP reductase; 5, methylmalonyl-CoA mutase; 6, methylmalonyl-CoA epimerase; 7, propionyl-CoA carboxylase; AAC, ATP/ADP translocator; ACP, acyl carrier protein; ALAT, alanine aminotransferase; BC-AAT, branched-chain amino acid aminotransferase; C I, complex I; ECH, enoyl-CoA hydratase; [Fe]-Hyd, [Fe]-hydrogenase; FRD/SDH, fumarate reductase/succinate dehydrogenase activity of complex II; FUM, fumarase; HCDH, 3-hydroxyacyl-CoA dehydrogenase; HICH, 3-hydroxyisobutyryl-CoA hydrolase; HID, 3-hydroxyisobutyrate dehydrogenase; LC-ACS, long-chain acyl-CoA synthetase; MDH, malate dehydrogenase; OMC, oxoglutarate/malate carrier protein; Pyr C, pyruvate carboxylase; SCS, succinyl-CoA synthetase; SOD, superoxide dismutase.
Figure 3Secretory proteins and virulence factors identified in the . Blastocystis sp. may release cysteine proteases, which could be processed by legumain. These proteases may attack intestinal epithelium together with other hydrolases, such as glysoside hydrolases. Protease inhibitors, some of which have been predicted to be secreted, could act on host proteases (digestive enzymes or proteases involved in the immune response). Some as yet uncharacterized secondary metabolites produced by polyketide synthase (PKS) identified in the genome could also participate in host intestinal symptoms. Adhesive candidate proteins (proteins with an immunoglobulin Ig domain) have been found. Finally, drug-resistant isolates of the parasite could be explained by the presence of multidrug resitance (MDR) proteins. Lightning bolts indicate potential toxic effects.